# Michael A. Davies

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-a-davies/

## Facts

| Field | Value |
| --- | --- |
| Citations | 53,045 |
| Field | Melanoma and MAPK Pathways |
| h-index | 100 |
| i10-index | 319 |
| Last Known Institution | Energy Institute |
| OpenAlex ID | https://openalex.org/A5048327749 |
| ORCID iD | https://orcid.org/0000-0002-0977-0912 |
| Works | 1,468 |

## Researcher papers

- [Genomic Classification of Cutaneous Melanoma](https://scholariq.org/papers/genomic-classification-of-cutaneous-melanoma/)
- [B cells and tertiary lymphoid structures promote immunotherapy response](https://scholariq.org/papers/b-cells-and-tertiary-lymphoid-structures-promote-immunotherapy-response/)
- [Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy](https://scholariq.org/papers/loss-of-pten-promotes-resistance-to-t-cell-mediated-immunotherapy/)
- [Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma](https://scholariq.org/papers/neoadjuvant-immune-checkpoint-blockade-in-high-risk-resectable-melanoma/)
- [Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab](https://scholariq.org/papers/anti-pd-1-therapy-in-patients-with-advanced-melanoma-and-preexisting-autoimmune/)
- [Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy](https://scholariq.org/papers/increased-tumor-glycolysis-characterizes-immune-resistance-to-adoptive-t-cell/)
- [Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients](https://scholariq.org/papers/specific-lymphocyte-subsets-predict-response-to-adoptive-cell-therapy-using/)

## Researcher topics

- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Researcher university

- [Energy Institute](https://scholariq.org/institutions/energy-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.